Cited by 73Nitric Oxide and Endothelin EffectsLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells

Open access
Sacre, Sandra M, Stannard, Anita K, Owen, James S·2003·FEBS Letters

Abstract

Although apolipoprotein E3 (apoE3) is atheroprotective, two common isoforms, apoE2 and apoE4, produce recessive and dominant hyperlipidaemias, respectively. Using a fluorescent assay, we report herein that apoE3 particles secreted from recombinant cells stimulate more nitric oxide release in cultured human EA.hy926 endothelial cells than apoE2 or apoE4 (141% more than controls vs. 61 or 11%). Phosphatidylinositol (PI) 3‐kinase inhibitors suppressed the apoE effect, while apoE receptor 2 (apoER2) was tyrosine phosphorylated. We conclude that apoE stimulates endothelial nitric oxide release in an isoform‐dependent manner, and propose that tyrosine phosphorylation of apoER2 initiates PI3‐kinase signalling and activation of nitric oxide synthase.

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(03)00261-8

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Phosphorylation of the tyrosine residue of the NPxY motif could abolish the interaction between the receptor and SNX17.

    “The interaction between the receptor and adaptor protein could be abolished by phosphorylation of the tyrosine residue of the NPxY motif [62], as has been reported for LRP1 [63].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sacre, S. M., Stannard, A. K., & Owen, J. S.
Affiliations
The Royal Free Hospital (GB)
Corresponding author
Owen, James S
Venue
FEBS Letters
Publisher
Wiley
Published
2003-03-18
Volume
540
Issue
1-3
Pages
181-187
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2091622438
Cited by
73
References
6
Citations by year
2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 10 · 2013: 3 · 2012: 3
FWCI
2.73
Type
journal article
Language
en
Open access
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
apolipoprotein E isoforms, APOE2, APOE3, APOE ε4, nitric oxide production, endothelial cells, EA.hy926 cells, tyrosine phosphorylation, nitric oxide synthase, hyperlipidemia, atheroprotection
MeSH terms
Wortmannin, Phosphoinositide-3 Kinase Inhibitors, Androstadienes, Animals, Apolipoproteins E, Cells, Cultured, Endothelium, Vascular, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Cricetinae, Humans, Nitric Oxide, Phosphorylation, Tyrosine, CHO Cells, Protein Isoforms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review